Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know (Q36679488)

15 August 2017

1 reference

title

Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know (English)

1 reference

15 August 2017

0 references

Klaus-Peter Hunfeld

1

1 reference

15 August 2017

Volker Brade

series ordinal

2

1 reference

15 August 2017

publication date

1 November 2006

1 reference

15 August 2017

published in

Vienna Clinical Weekly

1 reference

15 August 2017

volume

118

1 reference

15 August 2017

issue

21-22

1 reference

15 August 2017

page(s)

659-668

1 reference

https://scigraph.springernature.com/pub.10.1007/s00508-006-0693-z

15 August 2017

exact match

0 references

cites work

Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

Borrelia burgdorferi sp. nov.: Etiologic Agent of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

The Lyme disease vaccine: conception, development, and implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-006-0693-Z

Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.

21 January 2018

1 reference

12 December 2020

The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer).

1 reference

12 December 2020

Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin

1 reference

12 December 2020

New Chemotherapeutic Approaches in the Treatment of Lyme Borreliosis

1 reference

12 December 2020

Lyme disease--United States, 2000

1 reference

12 December 2020

Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans

1 reference

12 December 2020

Cultivation of Borrelia burgdorferi from the blood and a subcutaneous lesion of a patient with relapsing febrile nodular nonsuppurative panniculitis

1 reference

12 December 2020

Genomic Analysis of the Genes Encoding Ribosomal Proteins in Eight Eubacterial Species and Saccharomyces cerevisiae

1 reference

12 December 2020

Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis

1 reference

12 December 2020

[Effect of an antibiotic combination on the propagation of Borrelia burgdorferi, causative agent of Lyme disease]

1 reference

12 December 2020

In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values

1 reference

12 December 2020

In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto

1 reference

12 December 2020

Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi

1 reference

12 December 2020

In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics

1 reference

12 December 2020

Treatment of syphilis: a short critical review

1 reference

12 December 2020

Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones

1 reference

12 December 2020

Esterases in serum-containing growth media counteract chloramphenicol acetyltransferase activity in vitro

1 reference

12 December 2020

Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis

1 reference

12 December 2020

Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo

1 reference

12 December 2020

Failure of treatment with cephalexin for Lyme disease

1 reference

12 December 2020

Susceptibility of Borrelia afzelii strains to antimicrobial agents

1 reference

12 December 2020

Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment

1 reference

12 December 2020

Penetration of endothelial cell monolayers by Borrelia burgdorferi

1 reference

12 December 2020

Epidemiology of European Lyme borreliosis

1 reference

12 December 2020

Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings

1 reference

12 December 2020

In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi

1 reference

12 December 2020

Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans

1 reference

12 December 2020

Intracellular localization of Borrelia burgdorferi within human endothelial cells

1 reference

12 December 2020

New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances.

1 reference

12 December 2020

1 reference

12 December 2020

Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes

1 reference

12 December 2020

Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi

1 reference

12 December 2020

Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis

1 reference

12 December 2020

Antibiotics and increased temperature against Borrelia burgdorferi in vitro

1 reference

12 December 2020

Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae

1 reference

12 December 2020

The Spirochetal Etiology of Lyme Disease

1 reference

12 December 2020

parC mutations in fluoroquinolone-resistant Borrelia burgdorferi

1 reference

12 December 2020

European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis

1 reference

12 December 2020

In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies

1 reference

12 December 2020

Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?

1 reference

12 December 2020

In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi

1 reference

12 December 2020

Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents--possible implications for new therapeutic approaches to Lyme disease.

1 reference

12 December 2020

In vitro susceptibility of the Borrelia burgdorferi sensu lato complex to ABT-773, a novel ketolide

1 reference

12 December 2020

Macrolide resistance in Treponema pallidum in the United States and Ireland

1 reference

12 December 2020

In vitro activity of eight oral cephalosporins against Borrelia burgdorferi

1 reference

12 December 2020

Long-term Serological Follow-up of Patients Treated for Chronic Cutaneous Borreliosis or Culture-positive Erythema Migrans

1 reference

12 December 2020

Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis

1 reference

12 December 2020

In vitro and in vivo susceptibility of Borrelia burgdorferi

1 reference

12 December 2020

1 reference

12 December 2020

Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections

1 reference

12 December 2020

Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance

1 reference

12 December 2020

Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions

1 reference

12 December 2020

Heterogeneity of Borrelia burgdorferi in the skin

1 reference

12 December 2020

Natural synthesis of a DNA-binding protein from the C-terminal domain of DNA gyrase A in Borrelia burgdorferi

1 reference

12 December 2020

Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus

1 reference

12 December 2020

Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates

1 reference

12 December 2020

Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.

1 reference

12 December 2020

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

1 reference

12 December 2020

Localization of Borrelia burgdorferi in murine Lyme borreliosis by electron microscopy

1 reference

12 December 2020

Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans.

1 reference

12 December 2020

The bactericidal activity of sparfloxacin

1 reference

12 December 2020

In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy

1 reference

12 December 2020

Erythromycin resistance in Borrelia burgdorferi

1 reference

12 December 2020

In vitro activities of the everninomicin SCH 27899 and other newer antimicrobial agents against Borrelia burgdorferi.

1 reference

12 December 2020

ABT-773: a new ketolide antibiotic

1 reference

12 December 2020

Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans.

1 reference

12 December 2020

Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato.

1 reference

12 December 2020

Inactivation of diaminopyrimidines and sulfonamides in Barbour-Stoenner-Kelly medium for isolation of Borrelia burgdorferi

1 reference

12 December 2020

European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility

1 reference

12 December 2020

10.1007/S00508-006-0693-Z

Identifiers

DOI

1 reference

15 August 2017

1 reference